Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Explore various ways to save money that can help you pay off debt faster. Take steps today to improve your financial health!
21,659 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Veteran trader Peter Brandt projects a Bitcoin price path to between 300,000 and 500,000, contingent on the four-year...
A little-known rule may cap a household's Social Security checks when there are dependents. Here’s how the family max...
A new international ETF pairs overseas blue chips with a covered-call strategy to generate monthly distributions and ...
IDVO’s $445 million income engine is under renewed pressure as growth at Taiwan Semiconductor slows, raising question...
A sudden rise in sweetgreen stock often stirs chatter among traders and fans alike. This article explains the common ...
Bitcoin’s price moves higher even as on-chain activity lags. The surprising disconnect between bitcoin’s price and ne...
Jim Cramer cautions that AI stock surges can reverse sharply if earnings fail to accelerate, a warning that comes as ...
Investors chasing steady income weigh higher-yield ETFs against core dividend funds as rates move. This piece explore...
Bland, a San Francisco voice AI startup, raised $50 million in a Series C led by Dell Technologies Capital, defying d...
A rising share of retirees faces taxation on Social Security once pension income pushes total income beyond a $34,000...
HUD launches two tech-enabled pilots designed to increase housing supply and cut costs. The programs target robotics ...